-
公开(公告)号:US09283203B2
公开(公告)日:2016-03-15
申请号:US11818604
申请日:2007-06-15
IPC分类号: A61K31/353 , A23G1/56 , A23L1/30 , A23G1/48 , A61K31/7048
CPC分类号: A61K31/353 , A23G1/48 , A23G1/56 , A23G2200/14 , A23L33/105 , A23V2002/00 , A61K31/7048 , A61K2300/00 , A23V2200/322 , A23V2250/2116
摘要: This invention relates to compositions, and methods of use thereof, for (i) enhancing executive cognitive function(s) (for example, decision making, planning, working memory, multitasking, judgment, numerical problem-solving, reading comprehension), and/or (ii) increasing blood flow in brain vasculature, comprising administering to a subject in need thereof, certain polyphenols such as flavanols, procyanidins, or pharmaceutically acceptable salts or derivatives thereof.
摘要翻译: 本发明涉及组合物及其使用方法,用于(i)增强执行认知功能(例如,决策,规划,工作记忆,多任务,判断,数字解决问题,阅读理解)和/ 或(ii)增加脑脉管系统中的血流量,包括向有需要的受试者施用某些多酚,例如黄烷醇,原花青素或其药学上可接受的盐或衍生物。
-
公开(公告)号:US20080161386A1
公开(公告)日:2008-07-03
申请号:US11818604
申请日:2007-06-15
IPC分类号: A61K31/352 , A61P9/00
CPC分类号: A61K31/353 , A23G1/48 , A23G1/56 , A23G2200/14 , A23L33/105 , A23V2002/00 , A61K31/7048 , A61K2300/00 , A23V2200/322 , A23V2250/2116
摘要: This invention relates to compositions, and methods of use thereof, for (i) enhancing executive cognitive function(s) (for example, decision making, planning, working memory, multitasking, judgment, numerical problem-solving, reading comprehension), and/or (ii) increasing blood flow in brain vasculature, comprising administering to a subject in need thereof, certain polyphenols such as flavanols, procyanidins, or pharmaceutically acceptable salts or derivatives thereof.
摘要翻译: 本发明涉及组合物及其使用方法,用于(i)增强执行认知功能(例如,决策,规划,工作记忆,多任务,判断,数字解决问题,阅读理解)和/ 或(ii)增加脑脉管系统中的血流量,包括向有需要的受试者施用某些多酚,例如黄烷醇,原花青素或其药学上可接受的盐或衍生物。
-
公开(公告)号:USD463732S1
公开(公告)日:2002-10-01
申请号:US29146075
申请日:2001-08-02
申请人: Ian Andrew MacDonald
设计人: Ian Andrew MacDonald
-
公开(公告)号:US5968900A
公开(公告)日:1999-10-19
申请号:US875326
申请日:1997-09-29
IPC分类号: A23L1/305 , A61K31/198 , A61K38/28 , A61K31/195 , A61K31/70 , A61K31/715
CPC分类号: A61K31/7004 , A23L33/17 , A61K31/198 , A61K38/28
摘要: Compositions herein increased creatine retention and/or glycogen storage in muscle. A composition comprises creatine or its derivative and a carbohydrate or its derivative. The carbohydrate is in an amount by weight which is greater than the amount of creatine. The amount of carbohydrate and the amount of creatine are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions may be in the form of a pharmaceutical or a dietary supplement and are intended for use in the human or animal body. Other compositions comprise creatine or an active derivative together with insulin or an active derivative. The amount of creatine and the amount of insulin are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions including creatine and insulin may further contain a carbohydrate or its derivative. A method of increasing creatine retention in a human or animal body comprises causing an increase in blood plasma creatine concentration and causing a substantially simultaneous increase in blood plasma insulin concentration. A method of increasing glycogen storage in a human or animal body comprises causing an increase in blood plasma creatine carbohydrate concentration and causing a substantially simultaneous increase in blood plasma creatine concentration. The compositions to increase the creatine retention and/or glycogen storage in the muscle are administered by injection or ingestion.
摘要翻译: PCT No.PCT / GB95 / 02933 Sec。 371日期:1997年9月29日 102(e)日期1997年9月29日PCT 1995年12月15日PCT PCT。 出版物WO96 / 日期1996年6月20日本文中的组合物增加肌肉中的肌酸保留和/或糖原储存。 组合物包含肌酸或其衍生物和碳水化合物或其衍生物。 碳水化合物的重量含量大于肌酸的量。 碳水化合物的量和肌酸的量对于增加肌肉中的肌酸保留和/或糖原储存是有效的。 组合物可以是药物或膳食补充剂的形式,并且用于人或动物体内。 其它组合物包含肌酸或活性衍生物以及胰岛素或活性衍生物。 肌酸的量和胰岛素的量对于增加肌肉中的肌酸保留和/或糖原储存是有效的。 包含肌酸和胰岛素的组合物还可含有碳水化合物或其衍生物。 增加人或动物体内肌酸保留的方法包括引起血浆肌酸浓度的增加并导致血浆胰岛素浓度基本上同时增加。 增加人或动物体内糖原储存的方法包括引起血浆肌酸碳水化合物浓度的增加并导致血浆肌酸浓度基本上同时增加。 通过注射或摄取来施用增加肌肉中肌酸保留和/或糖原储存的组合物。
-
-
-